Microbiota analysis in the hemodialysis population - Focusing on Enterobacteriaceae

Abstract

Abstract Background: Infection is a recognized risk factor for mortality among hemodialysis (HD) population, including infection caused by Enterobacteriaceae. We aimed to investigate Enterobacteriaceae in gut microbiota among HD patients and to analyze associations between microbiota and clinical parameters. Methods: This prospective study of microbiota analysis in HD patients was conducted in April eMay 2019. A control group without recent antibiotic use or hospitalization was used for comparison. Stool samples underwent 16S rRNA sequencing, using Greengenes 16S rRNA database for microbiota analysis. Results: Among 96 hemodialysis (HD) patients, mean age was 61.9 0.8 years and mean duration of HD was 6.5 0.7 years. No significant differences were found in alpha diversity between HD and control groups (HD group 949.5, controls 898; p Z 0.16) although significant between-group differences were found in beta diversity (p < 0.001). At phylum level, HD group had a higher abundance of Firmicutes and Proteobacteria, but lower abundance of Bacteriodetes. At genus level, Escherichia-Shigella complex increased among HD patients who had hospitalization with 1 year (median 0.024 vs 0.004, p Z 0.054) and Klebsiella was associated with emergency room visit within 1 year among HD patients (p Z 0.002). Conclusions: Alpha diversity in HD patients is not lower than that in healthy controls but significant between-group differences are found in microbiota composition according to beta diversity, due to decreased Bacteriodetes and increased Firmicutes and Proteobacteria. Deeper microbiota analyses for Enterobacteriaceae are necessary. Whether change in dietary components can help to decrease mortality among dialysis population warrants further research.